An unexpected protein interaction promotes drug resistance in leukemia

[1]  S. Shurtleff,et al.  Transcriptome profiling of patient derived xenograft models established from pediatric acute myeloid leukemia patients confirm maintenance of FLT3-ITD mutation , 2017, Leukemia & lymphoma.

[2]  Dian-xing Sun,et al.  Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications. , 2016, Biomedical reports.

[3]  A. Sparreboom,et al.  ABCC4 Is a Determinant of Cytarabine‐Induced Cytotoxicity and Myelosuppression , 2016, Clinical and translational science.

[4]  J. T. Caldwell,et al.  CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells , 2014, Journal of Hematology & Oncology.

[5]  J. T. Caldwell,et al.  Acute Myeloid Leukemia Cells Harboring MLL Fusion Genes or with the Acute Promyelocytic Leukemia Phenotype Are Sensitive to the Bcl-2-selective Inhibitor ABT-199 , 2014, Leukemia.

[6]  A. Yu,et al.  ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. , 2014, Current pharmaceutical design.

[7]  Gary D Bader,et al.  Predicting PDZ domain mediated protein interactions from structure , 2013, BMC Bioinformatics.

[8]  Heather L. Mulder,et al.  An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. , 2012, Cancer cell.

[9]  V. Grantcharova,et al.  A systematic family-wide investigation reveals that ~30% of mammalian PDZ domains engage in PDZ-PDZ interactions. , 2011, Chemistry & biology.

[10]  Colin W. Taylor,et al.  Analysis of protein-ligand interactions by fluorescence polarization , 2011, Nature Protocols.

[11]  Corina I. García,et al.  Multidrug Resistance Protein 4 (MRP4/ABCC4) Regulates cAMP Cellular Levels and Controls Human Leukemia Cell Proliferation and Differentiation* , 2011, The Journal of Biological Chemistry.

[12]  Nir London,et al.  Sub‐angstrom modeling of complexes between flexible peptides and globular proteins , 2010, Proteins.

[13]  E. Erdfelder,et al.  Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses , 2009, Behavior research methods.

[14]  Rosalinde Masereeuw,et al.  Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. , 2008, Trends in pharmacological sciences.

[15]  L. Zon,et al.  Prostaglandin E2: Making More of Your Marrow , 2007, Cell cycle.

[16]  M. Zaccolo,et al.  Spatiotemporal Coupling of cAMP Transporter to CFTR Chloride Channel Function in the Gut Epithelia , 2007, Cell.

[17]  G. Grosveld,et al.  Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice. , 2007, Cancer research.

[18]  T. Kohno,et al.  Structural insight into the interaction between the p55 PDZ domain and glycophorin C. , 2007, Biochemical and biophysical research communications.

[19]  L. Zon,et al.  Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis , 2007, Nature.

[20]  T. Kohno,et al.  Solution structure of human erythroid p55 PDZ domain , 2006, Proteins.

[21]  J. Downing,et al.  Gene Expression Profiling of Pediatric Acute Myelogenous Leukemia Materials and Methods , 2022 .

[22]  J. Wijnholds,et al.  The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Zhe-Sheng Chen,et al.  Transport of Cyclic Nucleotides and Estradiol 17-β-d-Glucuronide by Multidrug Resistance Protein 4 , 2001, The Journal of Biological Chemistry.

[24]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[25]  A. Chishti,et al.  The PDZ Domain of Human Erythrocyte p55 Mediates Its Binding to the Cytoplasmic Carboxyl Terminus of Glycophorin C , 1997, The Journal of Biological Chemistry.

[26]  M. Cleary,et al.  Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL , 1997, The EMBO journal.

[27]  H. Drexler,et al.  The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines. , 1997, Leukemia research.

[28]  J. Gurney,et al.  Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia. , 1996, Blood.

[29]  A. Chishti,et al.  Complete genomic organization of the human erythroid p55 gene (MPP1), a membrane-associated guanylate kinase homologue. , 1996, Genomics.

[30]  A. Kingsman,et al.  A transient three-plasmid expression system for the production of high titer retroviral vectors. , 1995, Nucleic acids research.

[31]  G. Rivas,et al.  Rapid and accurate microfractionation of the contents of small centrifuge tubes: application in the measurement of molecular weight of proteins via sedimentation equilibrium. , 1993, Analytical biochemistry.

[32]  M. Brizzi,et al.  M‐07e human leukemic factor‐dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM‐CSF and IL‐3 , 1990, Journal of cellular physiology.

[33]  G. Cattoretti,et al.  Selective growth response to IL‐3 of a human leukaemic cell line with megakaryoblastic features , 1988, British journal of haematology.

[34]  M. Ogura,et al.  Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. , 1985, Blood.

[35]  B. Trumpower,et al.  Rapid reduction of cytochrome c1 in the presence of antimycin and its implication for the mechanism of electron transfer in the cytochrome b-c1 segment of the mitochondrial respiratory chain. , 1981, The Journal of biological chemistry.

[36]  Dian-xing Sun,et al.  Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications. , 2016, Biomedical reports.

[37]  A. Fulton,et al.  Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer. , 2015, Prostaglandins & other lipid mediators.

[38]  F. Russel,et al.  Special issue : Pharmacology in The Netherlands Multidrug resistance protein 4 ( MRP 4 / ABCC 4 ) : a versatile efflux transporter for drugs and signalling molecules , 2008 .

[39]  M. Sheng,et al.  PDZ domains and the organization of supramolecular complexes. , 2001, Annual review of neuroscience.